166Dy/166Ho-labeled porous hydroxyapatite microparticles for treatment of inflammatory joint diseases – Exploring the advantages of in vivo generator
Abstract Holmium-166 [T½ = 26.8 h, Eβ − (max) = 1.74 MeV (48.7%) and 1.85 MeV (50.0%); Eγ = 80.6 keV (10.6%)] is one of the most promising radionuclides in radiation synovectomy (RSV) for the treatment of inflammatory joint diseases, especially of large joints. However, short half-life of 166Ho is a...
Saved in:
| Main Authors: | Sourav Patra, Khajan Singh, Avik Chakraborty, Shahiralam Khan Mohammed, Sutapa Rakshit, Rubel Chakravarty, Sudipta Chakraborty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-02373-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dosimetric effectiveness in implants with distinct ho166-seed distributions in a prostate model
by: Viviane Vitória Bento Braga, et al.
Published: (2019-02-01) -
Dosimetric study on radioembolization with 166Ho poly L-lactic acid microspheres: dead time effects on prediction power
by: Bartolomeo Cassano, et al.
Published: (2025-07-01) -
Animal-based radiation absorbed dose evaluation of holmium-166 labeled hydroxyapatite particulates in liver malignancies
by: Reza Bagheri, et al.
Published: (2025-01-01) -
Effect of OSEM Reconstruction Iteration Number and Monte Carlo Collimator Modeling on <sup>166</sup>Ho Activity Quantification in SPECT/CT
by: Rita Albergueiro, et al.
Published: (2025-02-01) -
Assessment and clinical relevance of pulmonary shunt on 166Ho-Scout Imaging in hepatocellular carcinoma
by: Evelyn Vranken, et al.
Published: (2025-07-01)